Black Diamond Therapeutics, Inc. - Common Stock, par value $0.0001 per share (BDTX)

CUSIP: 09203E105

Q2 2020 13F Holders as of 30 Jun 2020

Type / Class
Equity / Common Stock, par value $0.0001 per share
Shares outstanding
58,000,000
Total 13F shares
22,835,597
Share change
+929,044
Total reported value
$959,367,654
Price per share
$42.16
Number of holders
79
Value change
+$39,864,306
Number of buys
50
Number of sells
16

Quarterly Holders Quick Answers

What is CUSIP 09203E105?
CUSIP 09203E105 identifies BDTX - Black Diamond Therapeutics, Inc. - Common Stock, par value $0.0001 per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Top shareholders of BDTX - Black Diamond Therapeutics, Inc. - Common Stock, par value $0.0001 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Holder Source Role / Reporting Ownership % Shares Holdings Value 12M Net Δ As of Details
NEA Management Company, LLC
13F
Company
5.9%
3,449,845
$86,074,000 31 Mar 2020
13F
RA CAPITAL MANAGEMENT, L.P.
13F
Company
4.5%
2,589,904
$64,618,000 31 Mar 2020
13F
Boxer Capital, LLC
13F
Company
3.5%
2,014,858
$50,271,000 31 Mar 2020
13F
Artal Group S.A.
13F
Company
2.9%
1,696,517
$42,328,000 31 Mar 2020
13F
FMR LLC
13F
Company
2.7%
1,588,010
$39,620,000 31 Mar 2020
13F
Bellevue Group AG
13F
Company
2.3%
1,330,000
$33,184,000 31 Mar 2020
13F
WELLINGTON MANAGEMENT GROUP LLP
13F
Company
2.2%
1,264,898
$31,101,000 31 Mar 2020
13F
PERCEPTIVE ADVISORS LLC
13F
Company
1.9%
1,104,656
$27,561,000 31 Mar 2020
13F
VANGUARD GROUP INC
13F
Company
1.1%
632,966
$15,794,000 31 Mar 2020
13F
DRIEHAUS CAPITAL MANAGEMENT LLC
13F
Company
1%
583,016
$14,546,000 31 Mar 2020
13F
BlackRock Finance, Inc.
13F
Company
0.98%
567,688
$14,164,000 31 Mar 2020
13F
DEERFIELD MANAGEMENT COMPANY, L.P.
13F
Company
0.92%
536,001
$13,373,000 31 Mar 2020
13F
Capital World Investors
13F
Company
0.91%
525,000
$13,099,000 31 Mar 2020
13F
Avoro Capital Advisors LLC
13F
Company
0.9%
521,750
$13,018,000 31 Mar 2020
13F
JENNISON ASSOCIATES LLC
13F
Company
0.74%
426,538
$10,642,000 31 Mar 2020
13F
FEDERATED HERMES, INC.
13F
Company
0.69%
400,000
$9,980,000 31 Mar 2020
13F
BVF INC/IL
13F
Company
0.65%
378,788
$9,451,000 31 Mar 2020
13F
FRANKLIN RESOURCES INC
13F
Company
0.52%
300,070
$7,487,000 31 Mar 2020
13F
Casdin Capital, LLC
13F
Company
0.5%
289,395
$7,220,000 31 Mar 2020
13F
Vivo Capital, LLC
13F
Company
0.43%
252,119
$6,290,000 31 Mar 2020
13F
STATE STREET CORP
13F
Company
0.33%
189,023
$4,716,000 31 Mar 2020
13F
LORD, ABBETT & CO. LLC
13F
Company
0.24%
137,732
$3,436,000 31 Mar 2020
13F
NORTHERN TRUST CORP
13F
Company
0.21%
122,506
$3,057,000 31 Mar 2020
13F
EMERALD ADVISERS, LLC
13F
Company
0.2%
114,490
$2,857,000 31 Mar 2020
13F
Logos Global Management LP
13F
Company
0.21%
123,465
$2,772,000 31 Mar 2020
13F
EMERALD MUTUAL FUND ADVISERS TRUST
13F
Company
0.19%
110,661
$2,761,000 31 Mar 2020
13F
JPMORGAN CHASE & CO
13F
Company
0.17%
100,386
$2,504,000 31 Mar 2020
13F
NORGES BANK
13F
Company
0.17%
100,000
$2,495,000 31 Mar 2020
13F
Atika Capital Management LLC
13F
Company
0.16%
95,000
$2,370,000 31 Mar 2020
13F
GEODE CAPITAL MANAGEMENT, LLC
13F
Company
0.16%
90,397
$2,255,000 31 Mar 2020
13F
GOLDMAN SACHS GROUP INC
13F
Company
0.16%
90,037
$2,246,000 31 Mar 2020
13F
OXFORD ASSET MANAGEMENT LLP
13F
Company
0.14%
78,385
$1,956,000 31 Mar 2020
13F
ArrowMark Colorado Holdings LLC
13F
Company
0.12%
70,000
$1,747,000 31 Mar 2020
13F
Nuveen Asset Management, LLC
13F
Company
0.06%
36,064
$900,000 31 Mar 2020
13F
Bank of New York Mellon Corp
13F
Company
0.05%
30,447
$760,000 31 Mar 2020
13F
MARSHALL WACE, LLP
13F
Company
0.05%
28,790
$718,000 31 Mar 2020
13F
Allianz Asset Management GmbH
13F
Company
0.04%
25,697
$641,000 31 Mar 2020
13F
CHARLES SCHWAB INVESTMENT MANAGEMENT INC
13F
Company
0.04%
25,553
$638,000 31 Mar 2020
13F
DAVIDSON KEMPNER CAPITAL MANAGEMENT LP
13F
Company
0.04%
25,000
$601,000 31 Mar 2020
13F
PRUDENTIAL FINANCIAL INC
13F
Company
0.04%
20,910
$522,000 31 Mar 2020
13F
AMERIPRISE FINANCIAL INC
13F
Company
0.03%
19,600
$488,000 31 Mar 2020
13F
STATE OF WISCONSIN INVESTMENT BOARD
13F
Company
0.03%
18,600
$464,000 31 Mar 2020
13F
CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM
13F
Company
0.03%
18,341
$458,000 31 Mar 2020
13F
WELLS FARGO & COMPANY/MN
13F
Company
0.03%
18,196
$454,000 31 Mar 2020
13F
Zimmer Partners, LP
13F
Company
0.03%
17,500
$437,000 31 Mar 2020
13F
FRED ALGER MANAGEMENT, LLC
13F
Company
0.03%
17,000
$424,000 31 Mar 2020
13F
DEUTSCHE BANK AG\
13F
Company
0.02%
13,625
$340,000 31 Mar 2020
13F
RHUMBLINE ADVISERS
13F
Company
0.02%
12,061
$301,000 31 Mar 2020
13F
VICTORY CAPITAL MANAGEMENT INC
13F
Company
0.02%
11,922
$297,000 31 Mar 2020
13F
BANK OF AMERICA CORP /DE/
13F
Company
0.02%
11,388
$284,000 31 Mar 2020
13F

Institutional Holders of Black Diamond Therapeutics, Inc. - Common Stock, par value $0.0001 per share (BDTX) as of Q2 2020

As of 30 Jun 2020, Black Diamond Therapeutics, Inc. - Common Stock, par value $0.0001 per share (BDTX) was held by 79 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 22,835,597 shares. The largest 10 holders included NEA Management Company, LLC, RA CAPITAL MANAGEMENT, L.P., BOXER CAPITAL, LLC, Artal Group S.A., FMR LLC, Bellevue Group AG, WELLINGTON MANAGEMENT GROUP LLP, PERCEPTIVE ADVISORS LLC, VANGUARD GROUP INC, and BlackRock Inc.. This page lists 79 institutional shareholders reporting positions in this security for the Q2 2020 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period

Compare Q2 2020 vs Q1 2020 Across Filers

Q1 2020 holders
65
Q2 2020 holders
79
Holder diff
14
Investor Q1 2020 Shares Q2 2020 Shares Share Diff Share Chg % Q1 2020 Value $ Q2 2020 Value $ Value Diff $ Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.